A case of insulinoma effectively treated with low-dose diazoxide

Atsushi Yasuda; Toshiro Seki; Natsumi Kitajima; Tanefumi Baba; Noriko Sasaki; Yoshie Kametani; Masami Seki; Kazuko Tanaka; Masayuki Oki

doi:10.1002/ccr3.3017

A case of insulinoma effectively treated with low-dose diazoxide

Clin Case Rep. 2020 Jun 3;8(10):1884-1889. doi: 10.1002/ccr3.3017. eCollection 2020 Oct.

Authors

Atsushi Yasuda¹, Toshiro Seki¹, Natsumi Kitajima¹, Tanefumi Baba², Noriko Sasaki³, Yoshie Kametani⁴, Masami Seki⁵, Kazuko Tanaka⁶, Masayuki Oki⁶

Affiliations

¹ Division of Nephrology, Endocrinology and Metabolism Department of Internal Medicine Tokai University School of Medicine Kanagawa Japan.
² Department of Neurosurgery Tokai University School of Medicine Kanagawa Japan.
³ Division of Rheumatology Department of Internal Medicine Tokai University School of Medicine Kanagawa Japan.
⁴ Department of Molecular Life Science Division of Basic Medical Science Tokai University School of Medicine Kanagawa Japan.
⁵ Seirei Numazu Hospital Shizuoka Japan.
⁶ Division of General Internal Medicine Department of Internal Medicine Tokai University School of Medicine Kanagawa Japan.

Abstract

Diazoxide is a benzothiadiazine that can be effective in managing hypoglycemia in frail patients with surgical risk. We report here a case of insulinoma effectively treated with diazoxide, as our report will be helpful for similar cases.

Keywords: diazoxide; hypoglycemia; insulinoma; neuroendocrine tumor.

Publication types

Case Reports